Man Group PLC Nektar Therapeutics Transaction History

Man Group PLC

$36 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.17 - $6.17 $63,894 - $124,362	-20,156 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $83,848 - $276,540	20,156 New	20,156 $109,000
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $1.08 Million - $1.33 Million	-65,154 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $894,157 - $1.37 Million	-53,995 Reduced 45.32%	65,154 $1.3 Million
Q4 2020 Feb 16, 2021	SELL	$15.77 - $19.03 $22,929 - $27,669	-1,454 Reduced 1.21%	119,149 $2.03 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $451,430 - $674,560	-27,211 Reduced 18.41%	120,603 $2 Million
Q2 2020 Aug 14, 2020	BUY	$16.86 - $23.44 $2.49 Million - $3.46 Million	147,814 New	147,814 $3.42 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $840,663 - $1.62 Million	-58,097 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$15.87 - $23.12 $2.24 Million - $3.26 Million	-140,863 Reduced 70.8%	58,097 $1.25 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $1.6 Million - $3.43 Million	94,554 Added 90.56%	198,960 $3.62 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $2.76 Million - $3.24 Million	89,138 Added 583.82%	104,406 $3.72 Million
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $341,474 - $501,182	-10,813 Reduced 41.46%	15,268 $513,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $5.69 Million - $10.6 Million	-187,122 Reduced 87.77%	26,081 $857,000
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $8.73 Million - $12.9 Million	187,807 Added 739.51%	213,203 $13 Million
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $305,435 - $689,787	-6,604 Reduced 20.64%	25,396 $1.24 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $1.84 Million - $3.47 Million	32,000 New	32,000 $3.4 Million

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$16.7 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$15.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$13.8 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$9.87 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.66 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account